InvestorsHub Logo

4toSchool

10/23/19 3:28 PM

#202264 RE: seven-up #202262

Richard Staelin, PhD, professor of business administration at The Fuqua School of Business at Duke University


Wow. That's impressive. He'd definitely be on my short list.

Hawk05

10/23/19 3:39 PM

#202267 RE: seven-up #202262

Welcome to the party! Posted that yesterday but I guess you missed it.

MedScape 183k followers in Twitter

Author of the article went to Binghamton University much like Sree and Prof. Kenneth McLeod

ddls

10/23/19 4:02 PM

#202268 RE: seven-up #202262

ZERO VALUE in the company's products, NONE!

Cheers!

yankee55

10/23/19 4:58 PM

#202274 RE: seven-up #202262

Great post seven-up! Dr.Staelin can make Actipatch a global brand name in a very timely manner if he becomes the CEO. Actipatch is a huge goldmine to be tapped and Dr. Staelin can open the gates to a gold rush with his leadership! His qualifications for becoming the CEO are spectacular and the share price will reflect this if indeed he lands the CEO position!

ddls

10/29/19 6:50 PM

#202829 RE: seven-up #202262

Long story short, BIEL is a super pink 17 year old long time scam dud? Public acceptance failed. Is it any wonder given what were looking at?

Cheers!